Home Trending Stocks Alterity Therapeutics Ltd. (ATHE) Stock Prices on the Rise Following Promising Progress...

Alterity Therapeutics Ltd. (ATHE) Stock Prices on the Rise Following Promising Progress of ATH434 Development

Alterity Therapeutics Ltd. (ATHE) stock prices were up by 8.77% as of the market closing on May 14th, 2021, bringing the price per share up to USD$1.24.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Solid Liquidity Position

In an update on company activities for the quarter ending 31st March 2021, ATHE announced a solid liquidity position of USD$32.8 million. Along with operational cash outflows amounting to USD$5 million, these numbers are in accordance with the company’s forecasts. The company is stockpiling cash reserves as it continues its ongoing preparations for the Phase 2 clinical trial for its leading drug candidate, ATH434 in patients with Multiple System Atrophy (MSA).

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

BioMUSE Natural History Study

A majority of ATHE’s efforts and resources were devoted to the bioMUSE Natural History study in MSA patients. The study being conducted at Vanderbilt University Medical center will facilitate the provision of important information and insights that will help inform patient selection and the design of the Phase 2 trial. With a schedule date later in 2021, the study has already enrolled 80% of its original target cohort but is now evaluating the feasibility to expand enrollment.

Michael J. Fox Grant

ATHE was awarded a USD$495,000 grant by the Michael J. Fox Foundation to supplement the evaluation of the pharmacological profile of ATH434. The work being done is expected to determine the optimal dose of ATH434 in future clinical trials of patients with Parkinson’s disease. This marks the second grant that ATHE has received from the Michael J. Fox Foundation for the development of ATH434.

Increased Exposure for ATH434

The growing scope of ATHE is made apparent by the regular invitations for the company to present at investor conferences and leading clinical and scientific events around the world. In January and March of 2021, ATHE CEO presented at various life science and healthcare conferences attended by various institutional fund managers and investors. The company was also a part of the Biotech Showcase that was hosted by JP Morgan as a satellite event at the world’s largest healthcare conference.

Promising Developments

ATHE also featured as a part of the 7th Annual International Congress of MSA’s poster presentation with the provision of further data on ATH434. Updates included new results of data on blood pressure following changes in body position, concluding that ATH434 did not lower blood pressure when people move to the standing position. This is a very significant development seeing how impaired maintenance of blood pressure is a vital issue with MSA.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Future Outlook for ATHE

Armed with a solid liquidity position to fund their development ventures for ATH 434 for the foreseeable future, ATH has made strides to significantly expand on the visibility of their leading drug candidate. Current and potential investors are hopeful that the company will be able to leverage the resources at its disposal to facilitate the commercialization and proliferation of ATH434 as a standard treatment for patients with MSA.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

CureVac Inc. (CVAC) stock soar during pre-market trading. Here’s what you should know?

CureVac Inc. (NASDAQ: CVAC) stock declined by 38.99% at the last close while the CVAC stock price gains by 11.34% in the pre-market trading...

Why Iconix Brand Group Inc (ICON) stock turnaround in the after-hours on Thursday?

Iconix Brand Group Inc (ICON) shares started the Thursday, June 17, 2021, trading be losing 1.87% and close the normal trading session at $3.14...

ISun Inc. (ISUN) stock surged during current market trading. Here’s the update

ISun Inc. (NASDAQ: ISUN) stock gained by 19.51% in the current market trading. iSun, based in Burlington, Vermont, is a company built on ideals...

The Trade Desk Inc. (TTD) stock plunged during pre-market. Here’s to know why?

The Trade Desk Inc. (NASDAQ: TTD) stock gained by 0.76% at last close whereas the TTD stock price declines by 90.03% in the pre-market...

Synaptogenix Inc. (SNPX) stock soars during after-hour trading. Why so?

Synaptogenix Inc. (NASDAQ: SNPX) stock gained by 6.33% at last close while the SNPX stock price rises further by 13.48% in the after-hours trading...

Victory Capital Holdings Inc. (VCTR) stock declined in the after-hour session. Here’s what you should know?

Victory Capital Holdings Inc. (NASDAQ: VCTR) stock declined by 1.89% at the last close while the VCTR stock price plunged by 0.76% in the...

Edesa Biotech Inc. (EDSA) stock surged during current market trading. Here’s to know why?

Edesa Biotech Inc. (NASDAQ: EDSA) stock gained by 4.22% in the current market trading. Edesa Biotech is a clinical-stage biopharmaceutical business dedicated on the...

CureVac Inc. (CVAC) stock soar during pre-market trading. Here’s what you should know?

CureVac Inc. (NASDAQ: CVAC) stock declined by 38.99% at the last close while the CVAC stock price gains by 11.34% in the pre-market trading...

Related News

CureVac Inc. (CVAC) stock soar during pre-market trading. Here’s what you should know?

CureVac Inc. (NASDAQ: CVAC) stock declined by 38.99% at the last close while the CVAC stock price gains by 11.34% in the pre-market trading...

Why Iconix Brand Group Inc (ICON) stock turnaround in the after-hours on Thursday?

Iconix Brand Group Inc (ICON) shares started the Thursday, June 17, 2021, trading be losing 1.87% and close the normal trading session at $3.14...

ISun Inc. (ISUN) stock surged during current market trading. Here’s the update

ISun Inc. (NASDAQ: ISUN) stock gained by 19.51% in the current market trading. iSun, based in Burlington, Vermont, is a company built on ideals...

The Trade Desk Inc. (TTD) stock plunged during pre-market. Here’s to know why?

The Trade Desk Inc. (NASDAQ: TTD) stock gained by 0.76% at last close whereas the TTD stock price declines by 90.03% in the pre-market...

Synaptogenix Inc. (SNPX) stock soars during after-hour trading. Why so?

Synaptogenix Inc. (NASDAQ: SNPX) stock gained by 6.33% at last close while the SNPX stock price rises further by 13.48% in the after-hours trading...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam